Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain

Stopped early · Not applicable

Conditions studied: Pain, Inflammation

In brief

The investigators hypothesize that perioperative administration of anakinra will reduce incisional pain by lowering the concentration of inflammatory mediators in surgical wounds. This knowledge is important because it suggests a new, previously unexplored pharmacological target for the control of postoperative incisional pain.

Key facts

Study ID
NCT01466764
Run by
Stanford University
People needed
13
Starts
2011-10-01
Expected to finish
2013-06-01
Last updated by the study team
2017-08-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.